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Long-term treatment of rats with FGF-2 results in focal
segmental glomeruloscierosis
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Long-term treatment of rats with FGF-2 results in focal segmental
glomerulosclerosis. Long-term treatment (8 and 13 weeks) of rats with
FGF-2 led to albuminuria and to increase in serum creatinine indicating
the development of chronic renal failure. Histologically, the classic picture
of focal segmental glomerulosclerosis (FSGS) was found; males were
more severely affected than females. Among the early changes podocyte
lesions were most prominent. Surprisingly, mitotic figures in podocytes
and a considerable fraction of bi(multi)nucleated podocyte profiles were
found in treated animals (roughly 16% in males, 8% in females). Since an
increase of cell number of podocytes was not evident, we conclude that
FGF-2 stimulates podocytes to re-enter the cell cycle and to undergo
mitosis (nuclear division). However, podocytes—probably due to their
highly differentiated cell shape in the adult—are unable to complete cell
division (cytokinesis) resulting in bi- or multinucleated cells; in others cell
division may fail totally leading to podocyte degeneration. Most podocytes
in FGF-2-treated rats exhibited degenerative changes including cell body
attenuation, extensive pseudocyst formation, widespread foot process
effacement, as well as detachments from the glomerular basement mem-
brane (GBM). The development of FSGS in this model is very uniform. In
the case of podocyte detachments from peripheral capillaries, parietal
cells become attached to naked GBM-areas, establishing the nidus for
development of a tuft adhesion to Bowman's capsule. Tuft adhesions grow
by encroaching of parietal cells onto adjacent capillary loops, resulting
eventually in a solid synechia with collapsed capillaries, that is, what
represents segmental sclerosis. The distribution of adhesions on the inner
surface of Bowman's capsule appeared to be random, including all
locations between the vascular and urinary pole. The two main aspects of
this study (inability of podocytes to replicate and development of FSGS
based on progressing podocyte degeneration) may be part of a vicious
cycle. FGF-2 stimulates podocytes to enter cell division thereby conveying
them into a hazardous situation. If a podocyte fails and degenerates it
cannot be replaced, aggravating the situation for the remaining cells and
possibly increasing their predisposition to respond to mitogenic stimuli.
Similar mechanisms may constitute the development of FSGS in other
experimental as well as human glomerulopathies.
Basic fibroblast growth factor (FGF-2, bFGF) is a highly
conserved 18 kD cationic protein [1]. As has been shown in vitro
and in vivo [2—4] it induces cell proliferation in a variety of cells
including fibroblasts, endothelial cells and vascular smooth muscle
cells. Its physiological mode of cellular release is unclear. In cell
injury FGF-2 is released from its cytosolic storage sites through
plasma membrane disruptions [5, 6]. Extracellularly, it is bound
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(and thereby stored) to heparan sulfate proteoglycans where it
may be released by heparin and heparinitinases [7, 8].
In the kidney, synthesis of FGF-2 has been demonstrated to
occur in cultured glomerular mesangial cells [9] and podocytes
[10]. FGF-2 is mitogenic to both of these cell types. The physio-
logical relevance of this stimulation is largely unknown. Subse-
quent to glomerular cell damage, FGF-2 is released from injured
cells (mesangial and epithelial) and acts synergistically with other
mitogenic compounds such as platelet-derived growth factor to
stimulate cell proliferation [11—13].
Mazué and co-workers [14] have shown that long-term treat-
ment of rats with FGF-2 induces conspicuous structural changes
in glomeruli, especially in podocytes consisting of cell hypertrophy
and widespread vacuolar degeneration. The present study was
designed to evaluate the response of kidney structures to chronic
exposure to FGF-2 in more detail. We wanted to see how the
structural lesions in glomeruli develop and how they progress to
glomerulosclerosis.
Methods
Eighteen male and 18 female Sprague-Dawley rats (7 weeks
old; males 176 to 200 g, females 133 to 146 g) were used in this
study. Half of each group, that is, nine males and nine females,
served as controls. They were kept individually in macrolon cages
in an animal house and were fed by giving them free access to
standard rat chow (Altromin TPF® N 1324) and tap water. All
animal experiments complied with the "Principles of Laboratory
Animal Care" (NIH Publication No. 86 to 23, revised 1985) and
the "German Law on the Protection of Animals".
The experimental animals received a daily subcutaneous injec-
tion of 320 xg FGF-2/kg body wt (recombinant human FGF-2; E.
Merck, Darmstadt, Germany), whereas the control animals were
injected by the vehicle (aqua pro injectione with 0.01% benzalko-
nium chloride). After 56 or 90 days, respectively, 12 male and 12
female animals (6 experimental and 6 control rats each) were
fixed by total body perfusion (see below). Those experimental
animals (3 per group) with rapidly proceeding proteinuria were
used at the first date. At day 63, a further group of 12 animals (3
experimental and 3 control rats of each sex) were fixed by total
body perfusion for immunocytochemical studies (see below).
Body weight was checked every week. After 4, 6, 8 and 12 weeks
a blood sample was taken by puncturing the retroorbital eye
plexus (under anesthesia with halothene) and urea and creatinine
were determined in the serum. At same time intervals, urine was
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collected over a period of 18 hours (including the night) to
measure albumin and creatinine excretion.
Total body perfusion was carried out as described previously
[15]. After anesthesia with Nembutal® (1.2 mI/kg body wt), the
abdominal cavity was opened and the kidneys were perfused
retrogradely via the abdominal aorta without prior flushing of the
vasculature. Perfusion pressure in the perfusing apparatus was set
at 220 mm Hg; perfusion was performed for three minutes. For
the structural investigations, the fixative contained 1.5% glutaral-
dehyde and 1.5% formaldehyde in phosphate buffered saline
(PBS, calcium- and magnesium free, 260 mOsm, pH 7.4) supple-
mented with 0.5 glliter picric acid. Immediately after perfusion the
kidneys were removed, weighed, cut into slices and immersed in
the same fixative for one day until further processing.
A middle piece of the left kidney was processed for light
microscopy following standard procedures. After embedding in
paraplast, 4 m thick sections were cut and stained with hema-
toxylin eosin.
Perfusion-fixed tissue for transmission electron microscopy
(TEM) was processed in two ways. First, the classic osmium
tetroxide (1% 0s04) postfixation technique and dehydration in a
graded series of ethanol was applied and, second, a modified
postflxation and staining technique was used which minimizes
treatment with 0s04 and uses tannic acid as a contrast agent with
subsequent cold dehydration of the specimens [16]. All samples
were embedded in Epon.
Semithin sections (1 j.tm thickness) were cut with glass knives
on a Reichert Ultracut, stained with azure Il—methylene blue and
examined by light microscopy (Polyvar 2, Reichert). Ultrathin
sections were cut with a diamond knife on the Reichert Ultracut
and stained with 5% uranyl acetate for 15 minutes and with
Reynold's lead citrate for two minutes. They were evaluated in a
Philips EM 301.
For scanning electron microscopy (SEM) 3 mm thick coronal
slices of the kidney were dried by the critical point technique
(Polaron, Watford, UK), mounted on aluminum stubs with silver
conductive paint, sputter coated with gold (10 nm) (Polaron), and
examined in a Philipscan 500 SEM at 25 kV.
Immunohistochemisty
For immunocytochemical studies the fixative contained 2%
paraformaldehyde in 0.1 M PBS. After five minutes of perfusion
the vasculature was cleared off the fixative by perfusion with 0.8 M
PBS for two minutes. Afterwards adequate tissue pieces were
shock-frozen in melting isopentane cooled by liquid nitrogen, and
stored at —80°C. Semithin frozen sections (1 tm thick) were
prepared with an Ultracut E/FC 4E microtome (Reichert-Jung).
Incubation was performed with one of the following antibodies: a
rabbit antiserum to basic fibroblast growth factor (FGF-2; Sigma,
Munich, Germany), a murine monoclonal IgG-antibody against
desmin (Clone DE-U-10; Sigma), and a goat antiserum against
vimentin (Sigma). Antibody binding was visualized with fluores-
cein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Di-
anova, Hamburg, Germany) or with biotinylated anti-mouse IgG
from sheep (Amersham, Braunschweig, Germany) followed by
Texas Red or Cy3-conjugated streptavidin (Amersham or Di-
anova), respectively. In addition, semithin frozen sections were
stained with tetramethyl-rhodamine B isothiocyanate (TRITC)-
labeled phalloidin (Boehringer, Mannheim, Germany) to demon-
strate F-actin.
Damage scoring
To assess glomerular damage, 100 consecutively encountered
glomeruli from the entire cortex in each animal were screened in
semithin Epon sections (1 gm). Pseudocysts, tuft appositions and
tuft adhesions to Bowman's capsule were included in the evalua-
tion in a graded weighting. The number of glomeruli with
pseudocysts only were factored by 1, glomeruli with appositions by
2 (generally also containing pseudocysts), and glomeruli with
adhesions by 3. The sum of the three values reflects the degree of
damage in each animal (weighted damage index). The number of
adhesions taken separately and expressed as percentage of total
number of glomeruli represents the sclerosis index (% SGS).
Morphometiy
Morphometric analysis was carried out with a semiautomatic
image analysis system (VIDS IV, AiTectron, Düsseldorf, Ger-
many) connected to a Zeiss photomicroscope. Glomerular volume
(V0; included by Bowman's capsule) and tuft volume (VT) were
estimated for each animal. In paraffin sections, sixty random cross
sectional profiles per animal were collected in a systematic order,
and the entire glomerular area (A0) as well as the tuft area (AT,
minimal convex polygon) were measured on a digitizing tablet at
a magnification of X 690. VG and VT were calculated from the
mean area, A0 or AT, using the formula:
VGOrT = (k)(AcIorT)3
where f3 = 1.38 (shape coefficient for spherical particles) and k =
1.1 (size distribution coefficient for spheres) [171. Values were
corrected for the effects of shrinkage during paraffin embedding
(roughly 48%, [18]).
Cell counts in superficial glomeruli were performed in semithin
(1 JLm) and ultrathin sections in the LM and TEM, respectively. In
light micrographs (final magnification X 600) 16 to 20 glomerular
profiles (fairly cut through the center of the glomerulus) per
animal were evaluated to obtain a semiquantitative estimate of
glomerular cells. In each glomerular profile the total number of
cell nuclei, that of endothelial and mesangial cells combined and
that of podocytes were determined. Since a considerable fraction
of podocytes were binucleated (see below) a better estimate of
cell number was achieved by factoring the number of podocyte
cell nuclei in each animal by the ratio 100/100 + % binucleated
cells.
The results were expressed as mean number of endothelial and
mesangial cells combined, and of podocytes per glomerular
profile. In addition, by relating the cell numbers to the measured
tuft area of each profile a rough estimate of numerical cell density
(NA) was calculated.
The incidence of binucleated (including multinucleated) podo-
cytes was estimated in electronmicrographs. Ultrathin sections
from one to two tissue blocks were mounted on single-hole grids.
The first 10 glomerular profiles per animal appearing consecu-
tively in the visual field of the TEM were photographed in their
entirety and printed at a final magnification of x 1200. The
number of podocyte profiles with more than one nuclear profile in
each animal was counted and expressed as percentage of the total
number of podocyte profiles with nuclei.
Results are reported as mean SD. Differences between the
two groups were tested by Student's I-test or Mann-Whitney test
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Table 1. Serum and urine data
Week 6 Week 8 Week 10 Week 13
Ualb
[mgfISh]
S
[mol/l]
5urea
[mmol/lJ
Ulb
[mg/18h]
Screa
[.tmol/l]
Surea
[mmolIl]
Ualb
[mg/18hJ
Screa
[jmol/l]
Surca
[mmol/l]
UaIh
[mgIl8h]
Screa
[.tmoli1]
Surea
[mmol/1]
Male
Co 0.27 32.3 5.9 0.30 33.2 5.4 0.25 35.3 5.5 0.21 35.0 5.7
±0.19 ±2.6 ±0.6 ±0.15 ±2.5 ±0.6 ±0.15 ± 1.5 ±0.8 ±0.09 ± 1.0 ±0.6
Exp 50.64 36.2 7.5 141.46 40.7 9.3 193.18 44.0 9.2 303.36 49.3 12.7
± 46.85** ± 3.1* ± 0.9** ± 132.35** ± 6.5* ± 1.9** ± 174.10 ± 4.4 ± 1.8 ± 78.37 ± 8.4 ± 4.1
Female
Co 0.11 37.3 6.32 0.11 32.5 6.4 0.14 43.0 7.4 0.13 41.0 7.8
±0.04 ± 1.0 ±0.7 ±0.02 ±2.8 ±0.7 ±0.04 ±3.0 ±2.4 ±0.03 ±5.2 ± 1.2
Exp 15.39 36.3 7.2 79.81 31.3 7.1 7.36 42.0 8.5 85.11 40.7 8.4
± 25.57** ± 3.2 ± 0.8 ± 150.34** ± 1.6 ± 1.2 ± 5.14 ± 1.0 ± 0.4 ± 31.47 ± 1.6 ± 0.1
Values are mean ± SD; Co and Exp, control and experimental animals; n = 6 per group in week 6 and 8, n 3 per group in week 10 and 13, there
no statistical comparisons were made. UaIb, urinary albumin excretion; Screa, serum creatinine; Surea, serum urea. Serum data: Student's r-test; urine data.
Mann-Whitney test: p < 0.01; *p < 0.05.
Table 2: General and glomerular data
Kidney weight
(left kidney; g)
and Kidney N0,/ NEfldO+MCJ
Damage scoring
Weighted
Body
weight [gJ
weight/bOg
body weight
VTft
[m3 x 10]
glomerular
profile [NJ
glomerular
profile [N]
NA(Podo)
[N/pm2 X b0J
NA(Endo+Mes)
[N/pm2 X 10] SGS [%]
damage
index
Male
Co 320 ± 35 1.39 ± 0.20
0.44 ± 0.05
1651 ± 209 8.9 ± 1.1 29.1 ± 3.5 0.86 ± 0.07 2.83 ± 0.31 0 0
Exp 313 ± 22 1.56 ± 0.28
0.50 ± 0.10
3035 ± 596*1 7.6 ± 1.0 38.8 ± 52b,1 0.48 ± 0.07*1 2.47 ± 0.24c,1 21.6 ± 30.0 16.2 ± 4.8
Female
Co 184 ± 0.85 ± 0.13a,3
0.46 ± 0.04
1138 ± 85a,3 8.8 ± 0.8 26.7 ± 2.7 1.05 ± 0.09l3 3.22 ± 0.29 0 0
Exp 193 ± 17a,4 1.00 ± 018b,4
0.52 ± 0.08
1998 ± 391a,2;b,4 8.0 ± 0.7 34.3 ± 4902 0.67 ± 0.14*2*4 2.82 ± 0.32 2.1 ± 1.2 11.7 ± 0.7
UaIb *** *** * **
Scrca ** N ** ***
Values are mean ± SD. n = 6 per group. VTuf(, average glomerular tuft volume; NPOdO and NEadO±Mes, average number of podocytes, endothelial and
mesangial cells per representative glomerular profile; NA(Podo) and NA(Endo+Mes), numerical density of cell types per unit tuft area; SGS, incidence
of segmental glomeruloscierosis.
Student's t-test: a, p <0.001; b, p <0.01; c, p <0.05; 1, Exp/Co male; 2, Exp/Co female; 3, Co/Co male/female; 4, Exp/Exp male/female.
The lower panel shows the results of Pearsson's correlation test (males and females pooled). U15, urinaly albumin excretion; Screa, serum creatinine
concentration. ***p < 0.01; **p <0.05; *p < 0.1 (considered as descriptive); N, no correlation.
[19]. The correlation of parameters of glomerular damage (func-
tional is serum creatinine and urinary albumin excretion; struc-
tural is incidence of sclerosis and weighted damage index) with
parameters suggestive as causative factors of the injury (tuft
hypertrophy, podocyte cell density, percentage of binucleated
podocytes) were tested by Pearson's correlation test [20]. For
these tests all experimental animals were pooled; with respect to
serum and urinary data, we always used the values of the last
collection period. All statistical analyses were performed with the
SPSS analysis program (Chicago, IL, USA).
Results
As can be seen from Table 1, the experimental animals
developed albuminuria, males considerably more than females.
Starting after about six weeks of treatment, serum creatinine and
urea concentrations increased in males, indicating the beginning
of chronic renal failure. The interanimal variation in both groups,
males and females, was considerable. Originally, it was planned to
treat all animals for 90 days. After eight weeks of treatment some
animals had developed quite severe albuminuria so that we feared
we might lose some animals. Therefore, we divided the animals
designed for structural evaluation into two groups (56 days and 90
days); the animals designed for immunocytochemical studies were
placed in between.
No significant differences in body weight nor in kidney weight
between controls and experimental animals were found (Table 2).
However, glomerular tuft volume increased in experimental ani-
mals in males as well as in females compared to the corresponding
controls. This increase was prominent: by a factor 1.84 in males
and 1.76 in females. Since kidney weight did not increase, this
increase in tuft volume reflects a marked hypertrophy of the
glomeruli which is not paralleled by a hypertrophy of the rest of
I
— S only occasionally encountered; mesangial proliferation with ma-trix deposition was even less frequently seen—even in most
seriously damaged profiles. On the other hand, ballooning of
individual capillary loops was a common finding in injured
glomeruli (Fig. 2). In the case of a peripheral location of
ballooned capillaries, appositions to Bowman's capsule were
frequent.
Cell proliferation
the kidney. Compared to males, females had significantly smaller
tufts in the control as well as experimental groups. Tuft hypertro-
phy correlated significantly with serum creatinine and albumin
excretion.
General histopathology
The experimental animals developed the classic picture of focal
segmental glomeruloscierosis (FSGS). As shown in Figure 1,
glomerular profiles exhibited quite different degrees of damage up
to segmental sclerosis. Significant correlations were found be-
tween the weighted damage index and urinary albumin excretion
as well as serum creatinine concentrations (Table 2).
When analyzing the details of glomerular injury, it can easily be
seen that podocytes are in the center of the pathogenetic process.
Podocytes were massively hypertrophied and the characteristic
podocyte lesions (pseudocyst formation and foot process efface-
ment) were widespread and dominant (Fig. 2). Compared to the
extensive elaboration of podocyte lesions, mesangial injuries were
discrete. Mesangiolysis and expansion of mesangial spaces were
The most surprising finding was the frequent occurrence of
binucleated podocytes and mitotic Figures in podocytes (Fig. 2).
In some animals almost in each glomerular profile at least one bi-
or multinucleated podocyte was found. In several cases binucle-
ated podocytes were traced in serial sections; in any of these cases
it could be established that the two (or more) nuclear profiles
were not simply two sections of one nucleus but that they really
belonged to two or more separate nuclei. All binucleated podo-
cytes exhibited severe lesions.
Mitotic figures in podocytes were found in treated male and
female rats; in other cells mitotic figures were not encountered.
Mitotic figures encountered in podocytes exhibited features of
deviation from a normal mitotic course (Fig. 3). Anaphase
chromosomes lying in close vicinity to undissolved portions of the
nuclear envelope and to a Golgi apparatus (Fig. 3A) may be
considered as minor deviations; dislocations of individual chro-
mosomes (Fig. 3B), vacuolar degeneration of the cytoplasm and
condensations of unknown material (Fig. 3A) in the vicinity
ofchromosomes appear to indicate failure of mitosis possibly
followed by cell necrosis.
Compared to the corresponding controls a significant increase
of endothelial and mesangial cells, but not of podocytes was found
(Table 2). Because of tuft volume enlargement the number
density of mesangial and endothelial cells was noticeably dimin-
ished, and that of podocytes drastically decreased. Podocyte
density was significantly lower in males than in females, in control
as well as experimental animals.
The counts of bi(multi)nucleated cells done at the EM-level are
given in Table 3. The fraction of bi(multi)nucleated cells in-
creased drastically under FGF-2 treatment, which was again more
pronounced in males than in females (roughly 16 vs. 8%). The
incidence of bi(multi)nucleated cells correlated significantly with
the structural estimates of glomerular damage as well as with
serum creatinine concentrations, and less convincingly with uri-
nary albumin excretion (Table 3).
Podocyte lesions
The majority of podocytes were damaged, many of them
severely. Binucleated podocytes generally exhibited severe le-
sions. The most prominent lesions were cell body attenuation
together with extensive pseudocyst formation (Figs. 2 and 4), and
foot process effacement. Throughout the tuft, podocytes were
attached to the GBM by coarse processes broadly enlarged to
cytoplasmic sheets or even by their cell bodies (Fig. 5A). Inside
the attached cell portions a dark staining layer of cytoskeletal
elements adhering to the basal cell membrane was regularly seen.
Structurally, it appeared to consist mainly of microfilaments.
Staining with phalloidine (not shown) confirmed the presence of
F-actin in these structures. Accumulation of absorption droplets
associated with vacuolar degeneration of the cell body cytoplasm
and extensive surface changes of the cell membrane ("microvil-
bus transformation") were also seen (Fig. 5 B, C).
1438 Krizet al: FGF-2 results in FSGS
Fig. 1. Renal cortex, over'iew. A group of glomerular profiles with degen-
erative lesions including segmental sclerosis is seen. Note the increase in
peritubular interstitium; some tubules are filled with homogenous dark
staining material. Male, FGF-2, 90 days treatment. LM (1 tm Epon
section) x—180.
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Fig. 2. Glomerular profile with moderate
changes. Several dilated capillaries (triangles)
are associated with fairly normal mesangial
structures. Cellular changes in podocytes are
conspicuous: two podocytes in mitosis with
large cell bodies (asterisks) and one
binucleated podocyte [1, 2] are seen. These
and other podocytes exhibit pseudocyst
formation (stars) and foot process effacement
(thin arrows). Female, FGF-2, 90 days. TEM
x—875.
In glomeruli with advanced injury detachments of podocytes
from the GBM were frequently seen (Fig. 5 C, D). Extensive
detachments were regularly encountered in conjunction with tuft
adhesions to Bowman's capsule. Rarely, necrotic podocytes were
also found (Fig. 5D).
Tuft adhesions
Tuft adhesions to Bowman's capsule were found in all experi-
mental animals with advanced glomerular degeneration; they
were quite differently developed. Early adhesions consisted of one
up to few capillary loops attached to one or few parietal cells.
Serial sections through a small adhesion clearly demonstrated the
circumscribed character of this lesion (Fig. 6). Even in these light
micrographs, but much better in TEMs (Fig. 7), it can be seen that
the attachment of a capillary ioop to Bowman's capsule occurs
consistently by affixation of parietal cells to the (naked) GBM.
The site of affixation of a capillary to a parietal cell was mostly
found at the outermost portion of a capillary (facing the parietal
epithelium), but frequently an attachment at more centrally
located portions of a capillary or even at the paramesangial GBM
was seen. The attachment of parietal cells to the GBM frequently
resulted in a gap in the parietal epithelium.
In more advanced adhesions (Figs. 8, 9 and 10), a tuft segment
broadly merged with Bowman's capsule. Inside the attached area
podocytes generally had disappeared, leaving behind naked cap-
illaries, which were mostly collapsed and embedded into an
extracellular matrix which was continuous with the basement
membrane of Bowman's capsule. The space inside these GBM
profiles was either completely empty (with opposing GBM layers
touching each other), contained cellular elements (probably rem-
nants of endothelial and/or mesangial cells) or it was filled with
hyaline material. Often, several of these naked GBM profiles were
4iCjta
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Fig. 3. Mitosis in podocytes. (A) Pairs of anaphase chromosomes (C) are
associated with a mitotic spindle and a centriole (arrowhead). At variance
to a comparable stage in a normal mitosis, the nuclear envelope (N) is not
fully dissolved and is found in the vicinity of chromosomes, as is a Golgi
field (G). Foot process effacement is evident by the presence of only a few
filtration slits (arrows). Female, FGF-2, 90 days. TEM, X —5800. (B) Pairs
of anaphase chromosomes (C) in a vacuolated (V) podocyte cell body.
One chromosome pair appears to be dislocated (arrow). Female, FGF-2,
90 days. TEM, >< —4800. (C) Chromosomes (C) in a severely injured
podocyte showing vacuolation (V) and cytoplasmic areas filled with
electron dense material (asterisks) of unknown origin. Male, FGF-2, 90
days. TEM+ X—5400.
Table 3. Bi(multi)nucleated podocytes
Podocytes with
more than one
nuclear profile
[%j
Males
Co
Exp
2.0 1.7
16.3
Females
Co
Exp
2.5 1.0
8.7 57b,2
WDI
SGS
VTUI, **
UaIh*
Crea' **
The left panel shows the incidence of bi(multi)nucleated podocytes in
males and females. Values are mean SD; n = 6 per group. Mann-
Whitney test: a, p < 0.01; b, p < 0.05. 1, Exp/Co male; 2, Exp/Co female.
The right panel shows the results of Pearsson's correlation test between
the percentage of bi(multi)nucleated podocytes (males and females
pooled) and structural as well as functional estimates of the glomerular
damage. WDI, weighted damage index; SGS, incidence of glomeruloscle-
rosis; VTCft, average glomerular tuft volume; UIb, urinary albumin excre-
tion; Screa, serum creatinine concentration. ***p < 0.01; **< 0.05;
<0.1 (considered as descriptive).
Tuft adhesions to Bowman's capsule appeared to be randomly
distributed. Adhesions were found at any location: at the vascular
pole comprising the first branches of the afferent arteriole, at the
urinary pole taking the shape of a so-called tip-lesion [21], as well
as at all positions in between the two poles.
Final glomerular degeneration
piled up, appearing in total as a curious structure consisting
almost exclusively of wrinkled GBM profiles. Capillaries occluded
by microthrombi were also encountered. Macrophages were seen
at various places, in mesangial areas as well as filling former
capillary lumina. Mesangial areas were not particularly promi-
nent; mesangial proliferation and deposition of newly synthesized
mesangial matrix were not encountered.
Tuft adhesions develop into segmental sclerosis. Actually, an
advanced tuft adhesion, that is, a solid synechia with a loss of
normal glomerular structures inside the adherent area, represents
what is called segmental sclerosis. In the most injured animals,
glomerular profiles were found which exhibited the progression of
the damage via engulfing an entire lobule (Fig. 10) to the entire
tuft (Fig. 11). Inside those severely affected profiles collapsed
capillaries and mesangium were piled up to stacks of wrinkled
GBM profiles. Inside these GBM profiles remnants of endothelial
and mesangial cells, macrophages, hyalinosis and microthrombo-
sis were seen; open capillaries were rare. The space outside those
GBM profiles frequently contained some leavings of Bowman's
space outlined by parietal epithelial cells; podocytes had disap-
peared. Most of the space outside the GBM was occupied by an
extracellular matrix which was continuous with extracellular ma-
terial of the former basement membrane of Bowman's capsule.
This matrix was of low electron density rich in fluid, and fuzzy in
character at most places.
When analyzing the glomerular profile shown in Figure 11
quantitatively, the area outside the collapsed GBM profiles (thus
the area of the former Bowman's space) comprises roughly 80%
Correlations
(males and females
pooled)
pp
0
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11), which corresponds to occluded capillaries and remnants of
the mesangium.
Immunocytochemistty
Podocytes in controls commonly exhibited a weak expression of
desmin, whereas in the experimental animals the intensity of
desmin expression in podocytes (including the binucleated podo-
cytes) was strong (Fig. 12), frequently surpassing in appearance
that of vimentin.
In regard to the expression of FGF-2 in the kidney, in both
control and experimental animals, staining with the antibody
against FGF-2 was only seen in cell bodies of podocytes; the
intensity of the reaction was not different between controls and
experimental animals. Staining at other sites of the glomerulus
was not encountered.
Discussion
Fig. 4. Scanning electron micrographs showing the outer aspect of glomer-
ular capillaries. (A) Overview. Podocyte cell bodies (1 to 4) are attenuated
and pulled over the outer surface of capillaries, thus covering major parts
of the filtration area; interdigitating foot processes are hardly visible.
Outlets of the subcell body spaces are narrow (arrows). Pseudocysts (stars)
are developed at several sites; a pseudocyst with an apical opening is seen
(asterisk) which has obviously developed in vivo. SEM, X —3000. (B) Two
pseudocysts whose cupolas have been cut off during the preparation
procedure allowing to inspect the inner surface of the cavity. A pseudocyst
may consist of multiple compartments which communicate with each
other; its floor is made up by interdigitating foot processes, thus by the
outer aspect of the filtration barrier (arrow). SEM, x —4300. (A) and (B)
male, FGF-2, 90 days.
of the total area. When subtracting the luminal area of patent
capillaries from the GBM-included area, only 15% of total area is
left (the black area shown in the accompanying drawing to Fig.
This study shows that long-term treatment of rats with FGF-2
results in the development of focal segmental glomerulosclerosis.
This development is based on progressive degeneration of podo-
cytes. FGF-2 is a strong mitogenic substance. A specific mitogenic
effect of FGF-2 to podocytes has been established by in vitro
experiments [10]. A recent study in the chicken supports this view
by in vivo data showing that during kidney development podo-
cytes, in contrast to all other kidney cells, accumulate FGF-2 in
the nucleus [22]. The present study shows that under FGF-2
treatment podocytes may enter the cell cycle, however, they
cannot complete cell division terminating in binucleated cells.
These bi- and multinucleated cells all exhibit severe lesions. We
argue that the entry of podocytes into mitosis creates a vulnera-
bility to mechanical stress (distension by the transmural pressure
gradient) which underlies glomerular degeneration (see below).
This suggestion is supported by significant correlations between
the percentage of bi(multi)nucleated cells and structural as well as
functional damage estimates (Table 3). Unspecific effects of
FGF-2 due to its polycationic nature cannot be fully excluded as
an additional causative factor. Polycationic substances such as
protamine sulfate are known to neutralize the negative charge of
the filtration barrier leading to proteinuria [23, 241. However,
mitotic activity of podocytes has never been reported in studies
after destruction of the glomerular polyanion by aminonucleo-
sides [25, 26].
Females and males in this study developed quite different
degrees of renal damage. Albuminuria, increase of serum creati-
nine and glomerular structural lesions including percentage of
binucleated profiles and sclerosis, were all much less pronounced
in females than in males (Table 2). A key to an understanding why
females were better protected may be contained in the observa-
tion that females had smaller glomeruli which did not hypertrophy
as much as in males, resulting in the maintenance of a comparably
high podocyte density.
FGF-2 reactivates podocytes in the adult for mitosis
Along with other investigators [27—30] we have come to the
assumption that podocytes in the adult are unable to replicate [31,
32]. The evidence for this hypothesis comes from studies which
showed that the number of podocyte cell nuclei does not increase
during postnatal nor during hypertrophic kidney growth [28—30,
33]. This hypothesis is consistent with the complex architecture of
these cells which is reminiscent to that of a neuron in several
Fig. 5. Podocyte lesions. (A) Binucleated 1, 2] podocyte with widespread foot process effacement. Very few filtration slit profiles (small arrows) are left.
Podocyte cell body and processes are broadly attached to the GBM. A conspicuous dark rim of cytoskeletal elements strictly follows the contours of
the attachment sites (thick arrows). Despite the absence of filtration slits, the endothelium maintains its fenestrated elaboration (arrowheads). Local
mesangiolysis is also seen (asterisks). TEM, x —3O5O. (B) Podocyte with a large pseudocyst. Extremely attenuated cytoplasmic sheets establish large
parts of the cyst wall. Its floor is fixed to the GBM and made up of podocyte processes separated by slits (arrows; identified at higher magnifications),
even if the number of slits is greatly reduced. Note the binucleated podocyte 1, 2]. C, capillary. TEM, x —-3050. (C) Binucleated [1, 2] podocyte with
advanced lesions. In addition to large pseudocysts (stars), the cytoplasm of this podocyte exhibits accumulation of lysosomal elements (L; "absorption
droplets") and widespread vacuolar degeneration. Detachments from the GBM are seen at several sites (arrows). C, capillary. TEM, X —2850. (D)
Severely damaged podocytes. A multinucleated (M), a binucleated [1, 2] and several other podocytes (asterisks) are seen which exhibit pseudocyst
formation, vacuolar degeneration and extensive detachments from the GBM (thin arrows). Part of a necrotic podocyte is also seen (star). A capillary
lumen is occluded by a macrophage (MA). C, capillary. TEM, x —3250. (A) to (D) males, FGF-2, 90 days.
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Fig. 6. Early adhesion, shown in a series of light micrographs. The adhesion has a maximal width of about 30 sm (in C through E). Also its depth,
evaluated by counting the number of sections from its beginning (B) to its end (I), is in the range of some 30 jrm. (A) is an overview of the entire
glomerular profile, showing that there are no sclerotic changes in any other part of the profile. Parietal cells (small arrows; at the LM level a clear cell
type identification is not always possible) attach to a patent peripheral capillary loop (best seen in C through F; marked by black dots; occluded or
collapsed capillaries are marked by stars). Between the attached parietal cells a gap has formed within the Bowman's capsule (thick arrows). Podocytes
in the adherent area are massively injured with prominent pseudocyst formation (asterisks). Male, FGF-2, 56 days. LM x 1000.
II,
A
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At a first glance the present results appear to contradict this
hypothesis. Long-term treatment with FGF-2 obviously stimulates
podocytes to re-enter the cell cycle. Podocytes under these
conditions are able to carry out and to finish mitosis. However,
they are unable to undergo cell division (cytokinesis), resulting in
binucleated cells. Thus, our hypothesis has to be modified to the
extent that podocytes in the adult may undergo mitosis but are
unable to replicate themselves. The occurrence of very volumi-
nous cell nuclei in some podocytes suggests that—in addition to
binucleated cells—also polyploid podocytes develop in response to
FGF-2.
Bi- and multinucleated podocytes are seen in a variety of
experimental [31, 34, 35] as well as human glomerulopathies
[36—39]. The pathophysiological relevance of bi(multi)nucleated
podocytes has never been established. This extreme form of cell
hypertrophy may be considered as an ultimate effort to cope with
increasing challenges. Such a situation may frequently be the
consequence of the inability to replace a lost podocyte.
Fig. 7. Early adhesion as seen by TEM. The outer aspect of a capillary loop
(C) is devoid of a podocyte cover. Instead, parietal cells (PA) are attached
to the GBM (arrows). Naked GBM areas (arrowheads) are seen at other
sites in the adherent area. The multilayered basement membrane of
Bowman's capsule appears to be thickened (stars). P0, podocytes. Male,
FGF-2, 90 days. TEM, x —6850.
respects. Cell division of podocytes appears to be possible only
during ontogeny as long as these cells maintain a simple cuboidal
cell shape. As soon as they differentiate into the octopus-like
phenotype of the adult they lose the ability for cell multiplication.
Development of FSGS occurs exclusively on the basis of
podocyte damage
Podocytes in this study develop a characteristic pattern of
lesions which are well known from other models of FSGS
including UNX-DOCA-hypertension [40], development of FSGS
subsequent to uninephrectomy in young rats [31], development of
FSGS in the Fawn-hooded rat (unpublished results from our lab
together with A. P. Provoost) and in the Milan normotensive rat
[41], in aminonucleoside nephrosis [42] and in Masugi nephritis
([43]; unpublished results from our lab together with I. Shirato).
Typical podocyte changes consist of cell hypertrophy, cell body
attenuation, pseudocyst formation, foot process effacement and
finally detachments from the GBM. These lesions have been
interpreted as a consequence of inability of these cells to cope in
growth with expanding outer capillary surfaces and/or to with-
stand increased mechanical strain due to increased wall tension in
ballooned capillaries 31, 33, 40]. This may hold true for the
present study as well. Due to tuft hypertrophy and decrease in
podocyte cell density, an individual podocyte in experimental
animals has to serve quite a larger GBM area than in controls.
In the present study a specific component adding to the
vulnerability of podocytes must be considered. Many podocytes
under FGF-2 treatment enter the cell cycle and apparently most
of them terminate in binucleated cells, whereas some of them
appear to fail and to undergo necrosis. No evidence was found
that podocytes are able to complete cell division.
When entering the cell cycle cells generally dissolve a great
proportion of their cytoskeleton; they round up in shape and allow
the development of the spindle [44, 451. Podocytes do not round
up when entering mitosis; they keep their processes by which they
are affixed to the GBM. However, they necessarily dissolve the
cytoskeleton in the center of their cell body. In our view, this
creates a particularly vulnerable stage in this process. If a podo-
cyte in this stage will be mechanically challenged (such as by an
increase of the transmural pressure gradient) it will probably fail.
Therefore, it may readily be supposed that the extensive podocyte
damage generally seen in binucleated cells may be the conse-
quence of such a specific imbalance.
The most severe podocyte lesion is detachment from the GBM.
Apart from functional consequences (proteinuria; discussed in
[24]), a denuded GBM area represents a pre-stage for the
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Fig. 8. Glomerular profile with an intermediate-sized adhesion at the vascular pole. In the adherent tuft area (demarcated by a hatched line) capillaries
are either occluded (small arrow), hyalinized (two arrows) or, in most cases, collapsed, forming wrinkled OBM profiles (arrowheads) which are
embedded into a weakly staining extracellular matrix. Remnants of Bowman's capsule protrude into the adherent area (long arrow). In the nonadherent
tuft area capillaries have open lumina. Lesions are mainly seen in podocytes, including pseudocyst formation (asterisks) and foot process fusion (two
arrowheads). Note the binucleated podocyte (star). The accompanying drawing delineates GBM-included area in the affected lobule. Open capillaries
are only found outside the adhesion; the GBM-included area inside the adhesion is compact (shown in black). Male, FGF-2, 90 days. TEM, X—680.
formation of a tuft adhesion to Bowman's capsule and thus a
pre-stage for the progression to glomeruloscierosis. In agreement
with previous studies [31, 33, 40, 3I the results of this study
suggest the following sequence of events leading to sclerosis. If a
"naked" GBM portion of a peripheral capillary comes into
contact with the parietal epithelium, a parietal cell will attach to
the GBM. The incidence of these contacts in damaged glomeruli
is high because injured capillary loops frequently bulge out of the
tuft apposing to Bowman's capsule and are frequently associated
with injured podocytes. The affixation of a parietal cell to a naked
GBM area represents the very beginning of the formation of a tuft
adhesion. It appears that the parietal cell is pulled in a direction
towards the center of the tuft because of its affixation to a capillary
loop. It locally dissolves from its lateral contact to adjacent
parietal cells resulting in the formation of a gap in the parietal
epithelium. At this site, the central part of the adhesion is
attached to the basement membrane of Bowman's capsule.
The growth of an adhesion occurs by spreading to adjacent
capillaries. A pre-condition for this mechanism is again the
detachment of podocytes from neighboring capillary loops. Based
on the progression of the podocyte damage the parietal epithe-
hum encroaches onto the tuft moving along the GBM, and
thereby the adhesion grows in width and depth. The mechanism
underlying the progressive degeneration of podocytes in the
vicinity of an adhesion is unknown. It has previously been argued
[31] that podocytes which are attached partly to a fixed and partly
to a movable tuft region are exposed to inadequate mechanical
strain due to the hindrance of free floating. In a theoretical
analysis mechanical deformations of podocyte surfaces at the
attachment site turned out to have the strongest effect in lifting
the cells from the GBM [46].
Inside a growing adhesion a plethora of degenerative changes is
seen (see above). Podocytes disappear. Capillaries collapse. The
remnants of those capillaries are seen as wrinlded GBM profiles
representing collapsed GBM sacks. At other sites hyahine material is
accumulated inside the GBM sacks, in areas of former capillaries as
well as mesangium. Other capillaries may be occluded by micro-
thrombi and macrophages are encountered in vascular lumina as well
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as within mesangial areas. The cells which have survived inside an
adhesion appear to be mostly mesangial cells. Signs of mesangial cell
proliferation, de novo matrix production and deposition are not
encountered. As a whole, an adhesion is characterized by a scarcity
of cells, that is, by former cellular elements vanishing.
These lesions associated with progressing tuft adhesion per-
fectly correlate with the definition of glomeruloscierosis given
recently by Rennke [47]: "Glomerulosclerosis consists of global or
segmental collapse of capillaries with disappearance of the cellu-
lar elements and microvascular lumina. Entrapment of foamy
0 
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Fig. 9. Advanced adhesion. On both sites the adhesion is delineated by parietal cells (long arrows) which attach to the flanks of the adhesion and to
naked GBM portions. The adherent tuft area consists of wrinkled GBM profiles (which represent collapsed capillaries and mesangium) embedded into
a wekly staining extracellular matrix. Towards the cortical interstitium this matrix is demarcated by processes of cortical fibroblasts (small arrows).
Cellular elements are rather sparse within the adhesion. The border to the nonadherent tuft area is marked by continuous double-tracked GBM profiles
which are naked towards the adhesion (arrowheads) and covered, at least partially, by podocytes at the opposite side. TEM, X — 1200. (B) Enlarged view
of a portion of (A) showing the collapsed GBM area which corresponds to a former lobule or at least part of a lobule. Inside the GBM only two patent
capillaries (1, 2) are seen. All other parts of this former lobule are collapsed and piled up as wrinkled GBM profiles. Five cell nuclei (stars) are
encountered inside the collapsed GBM belonging either to former mesangial or endothelial cells. The outer aspect of the collapsed GBM is almost
totally devoid of cellular elements. Remnants of podocytes are seen at few places (arrows). Note the fluid rich character of the extracellular matrix.
TEM, X —2600. (C) Enlarged view of (A) showing the parietal epithelium (P) encroaching the flank of the adhesion and attaching to the naked GBM
at a site (arrow) considerably distant from Bowman's capsule (P0, podocyte; C, capillary). TEM, x3300. (A) to (C) males, FGF-2, 90 days.
Fig. 10. Large adhesion. The borders of this large tuft adhesion to Bowman's capsule are demarcated by the points where the parietal epithelium
attaches to the flanks of the adhesion (thick arrows). Inside the adhesion the dominating structures are the wrinkled GBM profiles which represent
collapsed capillaries and mesangium. In between these profiles, thus outside the GBM, rather few cellular elements are seen (arrows); if they are
podocytes or parietal cells cannot be decided with certainty. Some profiles appear to be pre-necrotic (star). The extracellular spaces outside the GBM
are filled by a pale-staining matrix. This space is continuous with the cortical interstitium separated from the latter only by processes of cortical
fibroblasts which form an incomplete cover (arrowheads). The accompanying drawing highlights the extensive elaboration of the collapsed GBM-profiles
(shown in black); only few open capillary lumina are seen (also marked by asterisks in the original). Male, FGF-2, 90 days. TEM, x—1150.
macrophages, cellular debris, hyaline material, also known as velopment of this damage. We clearly show that this process
hyalinosis, and adhesion of the tuft to Bowman's capsule by begins with the adhesion, with a firm attachment of a parietal cell
synechia." The present study demonstrates the step-by-step de- to the GBM of a peripheral capillary loop. This event initiates a
t'if
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Fig. 11. Advanced sclerosis. To understand this picture the accompanying drawing explains the skeleton of this profile. It shows three GBM areas which
probably belong to three former lobules. The uppermost GBM area is almost totally collapsed or hyalinized. The GBM area in the middle contains still
few small capillaries with open lumina (marked by asterisks) but is otherwise also totally collapsed. The third GBM area contains an open capillary loop
(asterisk) and another capillary occluded by a macrophage (arrow). In addition, two regions (1, 2) can be delineated which contain remnants of
Bowman's space outlined towards outside by parietal cells (PA), towards inside by podocytes (P0). Otherwise the space outside the GBM profiles is
filled by a pale-staining extracellular matrix and cellular elements with cystic degenerations. Most of these cells are probably of parietal origin, but a
clear separation between parietal cells and podocytes of this site is not always possible. Male, FGF-2, 90 days. TEM, X -680.
chain of events which inevitably develop into segmental sclerosis.
Central to this development is the progressing collapse and/or
occlusion of capillaries (easily seen in the accompanying drawings
to Figs. 8, 10 and 11) based on a progressing degeneration of
podocytes.
Relevance of FGF-2 in other glomerulopathies
Podocytes not only respond to FGF-2 but they also appear to
synthesize and store FGF-2 in vivo and in vitro [10]. This agrees
with our findings showing immunoreactivity of podocytes to
antibodies against FGF-2 in control and in treated animals. The
physiological relevance of FGF-2 production in podocytes is
unknown. Under pathological conditions FGF-2 is thought to be
released from injured podocytes. Findings in endothelial cells [481
suggest that complement activation on podocyte surfaces may
trigger FGF-2 release from podocytes. FGF-2 released from
injured cells [5] may act in an autocrine and paracrine manner.
The effect of such a stimulation is unclear. It has been suggested
that weak FGF-2 stimuli might become relevant in those podo-
cytes that have become more sensitive to FGF-2 due to an
up-regulation of FGF-2 receptors by prior injury. In this respect,
Floege and co-workers [49] were able to show that rats which
received a subnephritogenic dose of Heymann serum develop
glomeruloscierosis by an additive treatment with small doses of
FGF-2 (which did not cause any injury when given to unpre-
treated rats). These authors conclude that FGF-2 release from
injured podocytes may act synergistically with other damaging
mechanisms. The teleology behind such a complicity remains
unclear.
Recently the development of HIV-associated nephropathy has
been linked to FGF-2 [50]. HIV-nephropathy consists of a rapidly
progressing focal glomerulosclerosis [51] characterized by severe
podocyte lesions reminiscent of those observed in the present
study [52, 53]. Transgenic mice expressing the HIV-1 gene
developed glomerulosclerosis; by immunocytochemistry the HIV-
related protein was found in glomeruli of affected animals [54].
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the primary event, and thus agrees with previous suggestions that
this pattern of FSGS is indicative of random toxic damage to the
glomerulus {21}. The development of sclerosis is characterized by
degenerative and collapsing processes. Mesangial proliferation
and/or synthesis and deposition of mesangial matrix are not
involved.
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Fig. 12. Immunostaining pattern for desmin in glomeruli. Compared to
controls (A), staining for desmin is drastically increased after FGF-2
treatment (B). Cytoplasm of binucleated podocytes [arrow; verified by
nuclear counterstaining shown in (C)] stains strongly. Male, FGF-2, 65
days. LM, X—300.
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